Edwards Lifesciences Corporation (EW) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Irvine, CA, United States. Der aktuelle CEO ist Bernard J. Zovighian.
EW hat IPO-Datum 2000-03-27, 15,800 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $45.42B.
Edwards Lifesciences Corporation is a global medical device company headquartered in Irvine, California, specializing in structural heart disease treatment and critical care monitoring solutions. The company develops and markets minimally invasive transcatheter heart valve replacement and repair products, including the PASCAL and Cardioband systems for treating mitral and tricuspid valve diseases, as well as surgical structural heart solutions such as the INSPIRIS aortic valve and HARPOON Beating Heart Mitral Valve Repair System. Additionally, Edwards Lifesciences provides advanced hemodynamic monitoring systems and predictive software solutions for intensive care settings to help clinicians manage patient heart function and prevent critical complications. Operating since 1958, the company serves markets across the United States, Europe, Japan, and internationally through both direct sales and independent distributors.
